4-88460121-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016323.4(HERC5):c.416A>T(p.Lys139Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000391 in 1,586,922 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016323.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HERC5 | NM_016323.4 | c.416A>T | p.Lys139Ile | missense_variant | 3/23 | ENST00000264350.8 | |
HERC5 | XM_011532022.3 | c.416A>T | p.Lys139Ile | missense_variant | 3/21 | ||
LOC102723458 | XR_938972.3 | n.19+7510T>A | intron_variant, non_coding_transcript_variant | ||||
LOC102723458 | XR_938976.3 | n.76+7510T>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HERC5 | ENST00000264350.8 | c.416A>T | p.Lys139Ile | missense_variant | 3/23 | 1 | NM_016323.4 | P1 | |
HERC5 | ENST00000508695.1 | n.364A>T | non_coding_transcript_exon_variant | 3/4 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152184Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000284 AC: 7AN: 246464Hom.: 0 AF XY: 0.0000375 AC XY: 5AN XY: 133238
GnomAD4 exome AF: 0.0000383 AC: 55AN: 1434620Hom.: 0 Cov.: 26 AF XY: 0.0000378 AC XY: 27AN XY: 714938
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 22, 2023 | The c.416A>T (p.K139I) alteration is located in exon 3 (coding exon 3) of the HERC5 gene. This alteration results from a A to T substitution at nucleotide position 416, causing the lysine (K) at amino acid position 139 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at